Tissue-Level Effects of Adipolin (CTRP12) in Experimental Disease Models: A Systematic Review
VITALIS JOURNAL · 30.04.2026 · 2 (1) · 24-35
DOI: 10.65782/vjh.15 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift VITALIS JOURNAL, online erschienen am 30.04.2026. Verfasst von Hatip Enfal BAŞAR. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adipolin, also known as C1q/TNF-related protein 12 (CTRP12), has emerged as an adipokine of interest because of its reported insulin-sensitizing and anti-inflammatory properties. This systematic review examined the tissue-level effects of adipolin across experimental disease models, with specific emphasis on histological, immunohistochemical, and ultrastructural outcomes. The review was conducted in accordance with PRISMA principles, and the literature search was performed in PubMed and Web of Science using the terms “adipolin,” “CTRP12,” and “C1q/TNF-related protein 12.” Studies were included when they reported tissue-based morphological findings following adipolin administration or altered adipolin expression in experimental settings; studies restricted to serum biomarkers or lacking tissue-level data were excluded. The available evidence indicates that increased adipolin activity is generally associated with reduced inflammatory infiltration, attenuation of fibrosis, lower apoptotic burden, and preservation of tissue architecture, particularly in cardiac and renal models. Nevertheless, substantial methodological heterogeneity across the included studies limits direct comparability. Taken together, the current literature supports a potentially protective role for adipolin at the tissue level, while also underscoring the need for more standardized morphological reporting to improve interpretability and cross-study synthesis.
Zitieren
APA
BAŞAR, H. E. (2026). Tissue-Level Effects of Adipolin (CTRP12) in Experimental Disease Models: A Systematic Review. VITALIS JOURNAL, 2(1), 24-35. https://doi.org/10.65782/vjh.15
Vancouver
BAŞAR HE. Tissue-Level Effects of Adipolin (CTRP12) in Experimental Disease Models: A Systematic Review. VITALIS JOURNAL. 2026;2(1):24-35. doi:10.65782/vjh.15
BibTeX
@article{BAAR2026,
author = {BAŞAR, Hatip Enfal},
title = {Tissue-Level Effects of Adipolin (CTRP12) in Experimental Disease Models: A Systematic Review},
journal = {VITALIS JOURNAL},
year = {2026},
volume = {2},
number = {1},
pages = {24--35},
doi = {10.65782/vjh.15}
}
EUVIMED